S-DEXTROSE/GLYCERIN/PHENOL 25/25/2.5% INJ SOLN, 30 ml glass vial, Rx Only, Red Mountain Compounding Rx
Published November 13, 2019 · Recall initiated: August 12, 2019
Summary
FDA records drug Class II recall D-0210-2020, published November 13, 2019 and initiated August 12, 2019. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: 8x30 ml glass vial; Lot: Lot #: S07292019DH@13, Exp 8/29/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Distributor
- Nationwide in the USA
- Lot
- Lot #: S07292019DH@13, Exp 8/29/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMETHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDATEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDADEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAPYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding RxNovember 3, 2021
- FDAS-CALM INJECTION, (MAG S04/GABAPENTIN/TAURINE/THEANINE 50/50/50/50MG/ML) MDV, 10 ml glass vial, Red MountainNovember 13, 2019
- FDAS-DEXPANTHENOL 250MG/ML MDV INJ SOLN, 30ML glass vials, RX Only, Red Mountain Compounding RXNovember 13, 2019
Questions about this recall
Was S-DEXTROSE/GLYCERIN/PHENOL 25/25/2.5% INJ SOLN, 30 ml glass vial, Rx Only, Red Mountain Compounding Rx recalled?
Yes. FDA published recall D-0210-2020 on November 13, 2019. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter